Prospects for antibacterial therapy of prolonged and recurrent rhinogenous sinusitis, and sinusitis with comorbidities
https://doi.org/10.21518/2079-701X-2016-6-12-17
Abstract
The problem of acute sinusitis (AS) continues to be relevant in today's healthcare, what is explained by several reasons. First of all, it is not only that the incidence of AS did not decrease over the past years; moreover, it demonstrates sustainable growth both in Russia and wordlwide. For example, 16% of the US adult population present with sinusitis every year. [1] In Russia, 10 million people suffer from AS every year, although the figure can be low since only severe manifestations of the disease are recorded. [2] According to the latest statistics from the Department of Health of Moscow, the prevalence of sinusitis is 1420 cases per 100 thousand adults. [3]
About the Authors
A. I. Kryukov
Research and Clinical Otorhinolaryngology Institute named after L.I. Sverzhevskiy
Russian Federation
Russian Federation
N. L. Kunelskaya
Research and Clinical Otorhinolaryngology Institute named after L.I. Sverzhevskiy
Russian Federation
Russian Federation
A. V. Gurov
Research and Clinical Otorhinolaryngology Institute named after L.I. Sverzhevskiy
Russian Federation
Russian Federation
G. N. Izotova
Research and Clinical Otorhinolaryngology Institute named after L.I. Sverzhevskiy
Russian Federation
Russian Federation
M. A. Yushkina
Research and Clinical Otorhinolaryngology Institute named after L.I. Sverzhevskiy
Russian Federation
Russian Federation
O. A. Kiselyova
Research and Clinical Otorhinolaryngology Institute named after L.I. Sverzhevskiy
Russian Federation
Russian Federation
References
1. Anand VK. Epidemiology and economic impact of rhinosinusitis. Ann Otol Rhinol Laryngol Suppl, 2004, 193: 3-5.
2. Лопатин А.С. Принципы лечения острых и хронических синуситов. Фармакотерапия болезней уха, горла и носа с позиций доказательной медицины: Лекционный образовательный курс. М., 2006. С. 15-23.
3. Крюков А.И., Студеный М.Е., Артемьев М.Е. и др. Лечение пациентов с риносинуситами: возможности консервативного и оперативного воздействия. Медицинский совет, 2012, 11: 92-96.
4. Страчунский Л.С., Белоусов Ю.Б., Козлов С.Н. Антибактериальная терапия. Практическое руководство. М., 2000.
5. Garrison MW, Campbell RK. Identifying and treating common and uncommon infections in the patient with diabetes. Diabetes Educ, 1993, 19(6): 522-529; quiz 530-1.
6. Lin Y, Sun Z. Current views on type 2 diabetes. J. Endocrinol., 2010, 204: 1-11.
7. Wellen KE, Hotamisligil GS. Inflammation, stress, and diabetes. J. Clin. Invest., 2005, 115: 1111-1119.
8. Юшкина М.А. Особенности течения гнойно-воспалительных заболеваний ЛОР-органов у больных сахарным диабетом. Автореф. дис.. канд. мед. наук. Москва, 2012. 25 с.
9. Boyko El, Lipsky BA. Infection and diabetesю. M.I. Harris et al. (ed) Diabetes in America. 2nd ed. National Institute of Health, 1995: 485-500.
10. Бойкова Н.Э., Элькун Г.Б. Острая гнойная патология ЛОР-органов: подходы к лечению. РМЖ, 2009, 17(2): 78-82.
11. Руководство по очаговой инфекции в оториноларингологии. Под ред. Пальчуна В.Т., Крюкова А.И., Магомедова М.М. М.: Геотар-М., 2015, 224 с.
12. Пальчун В.Т., Михалева Л.М., Гуров А.В., Мужичкова А.В. Особенности формирования хронического воспаления в верхнечелюстной пазухе. Вестник оториноларингологии, 2011, 2: 5-7.
13. Петухова П.В. Особенности метаболизма слизистой оболочки верхнечелюстной пазухи в норме и при различных формах гайморита: Дис.. канд. мед. наук. М., 2004. С. 103.
14. Владимирова Е.Б. Морфофункциональные изменения слизистой оболочки верхнечелюстных пазух после радикального хирургического лечения: Автореф. дис. канд. мед. наук. М., 2002, с. 24.
15. Крюков А.И., Гуров А.В., Изотова Г.Н. Возможности современных макролидов в стартовой терапии острого бактериального синусита. РМЖ, 2012, 20(27): 1374-1377,
16. Lopatin A.S. The principles of treatment of acute and chronic sinusitis. Evidence-based pharmacotherapy of ear, nose and throat diseases: A training course of lectures. М., 2006. P. 15- 23.
17. Kryukov A.I., Studeny M.E., Artemyev M.E. et al. Treatment of patients with rhinosinusitis: prospects for conservative and surgical impact. Meditsinskiy Sovet, 2012, 11: 92- 96.
18. Strachunskiy L.S., Belousov Y.B., Kozlov S.N. Antibiotic therapy. Practical guide. М., 2000.
19. Boikova N.E., Elkun G.B. Acute purulent pathology of ENT: treatment approaches. RMZ, 2009, 17(2): 78-82.
20. Manual on focal infections in otorhinolaryngology. Ed. by Palchun V.T., Kryukov A.I., Magomedov M.M. М.: Geotar, 2015, 224 p.
21. Palchun V.T., Mikhaleva L.M., Gurov A.V., Muzhichkova A.V. The specifics of formation of chronic inflammation in the maxillary sinus. Vestnik Otorinolaringologii, 2011, 2: 5-7.
22. Petukhova P.V. The specific metabolism of the maxillary sinus mucosa in health and in various forms of sinusitis: Thesis of PhD in medicine. М., 2004. P.103.
23. Vladimirova E.B. Morphological and functional changes in the mucosa of the maxillary sinus after radical surgical treatment: Abstract of thesis for PhD in medicine. M.: 2002, p.24.
24. Kryukov A.I., Gurov A.V., Izotova G.N. The prospects for present-day macrolides in the initial treatment of acute bacterial sinusitis. RMZ, 2012, 20(27): 1374-1377.
25. Yushkina M.A. The specific course of chronic purulent-inflammatory diseases of ENT in patients with diabetes. Abstract of thesis for PhD in medicine. Moscow, 2012. 25 p
Review
For citations:
Kryukov AI, Kunelskaya NL, Gurov AV, Izotova GN, Yushkina MA, Kiselyova OA. Prospects for antibacterial therapy of prolonged and recurrent rhinogenous sinusitis, and sinusitis with comorbidities. Meditsinskiy sovet = Medical Council. 2016;(6):12-17. (In Russ.) https://doi.org/10.21518/2079-701X-2016-6-12-17
Views:
716
Email this article 